Objective: The primary objective of this study is to assess subjective changes in mood and anxiety symptoms before, during, and after administration of the microbial therapeutic. The secondary objectives of this study are ...

Background: There is growing evidence that individual EEG differences may aid in classifying patients with major depressive disorder (MDD) and also help predict clinical response to antidepressant treatment. This study ...

Objective: Primarily, to determine the effect of olanzapine augmentation therapy on sleep architecture, specifically slow wave sleep (SWS), in the treatment of depression. Secondarily, to determine the effect of olanzapine ...

Objective: The primary objective of this study is to investigate the effects of desvenlafaxine, a serotonin-norepinephrine reuptake inhibitor, on sleep architecture in depressed patients, with a focus on changes in slow ...

The costs of mental illness - economic, social, and human - are immense. However, the demand for evidence-based non-pharmaceutical therapies appears to exceed the availability of these services, and when therapy is available, ...

Introduction: Depression negatively impacts olfactory functioning and as such, olfactory dysfunction has been found in individuals with depression. Expansions of this research have demonstrated an improvement in olfactory ...

Background: People with depression struggle with cognitive impairments such as decreased working memory. The brain areas associated with working memory, such as the prefrontal cortex and hippocampus are negatively affected ...

Current research regarding the stigmatization of mental illnesses focuses mainly on quantitative data. There is insufficient data regarding the thoughts, feelings, and experiences of people with mood disorders. This thesis ...

Background: Previous research has found links between olfactory deficits and depression. Olfactory ability is restored with successful treatment with antidepressant medication. Electroconvulsive therapy (ECT) and repetitive ...